Inarandomisedcontrolledtialof a newtreatmentfor preventing recumrenceof stroke,1000patients are
randomisedtothenewtreatmentand1000tostandardtherapv.Atotauof66patientsreceivinqthenew
treatment suffered recurrentstroke.comoaredwth11Ointhecontrouarm.
WhatwasthereLativeriskreduction?
4.4%
6.6%
11%
40%
60%
@1MINENDOCRINE
